Back to top
more

Omnicell (OMCL)

(Delayed Data from NSDQ)

$44.48 USD

44.48
281,169

-0.78 (-1.72%)

Updated Aug 30, 2024 03:59 PM ET

After-Market: $44.31 -0.17 (-0.38%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Avanos Medical (AVNS) Q1 Earnings, Revenues Top Estimates

Avanos Medical's (AVNS) first-quarter 2022 results reflect strength in the Pain Management segment.

DaVita (DVA) Misses on Q1 Earnings, Reiterates FY22 EPS View

Despite strength in dialysis patient service revenues, DaVita (DVA) records an overall soft Q1 performance.

CPSI vs. OMCL: Which Stock Should Value Investors Buy Now?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Quidel (QDEL) Q1 Earnings, Revenues Surpass Estimates, Up Y/Y

Quidel's (QDEL) robust performance across two of its product categories drives its first-quarter 2022 top line.

CONMED's (CNMD) Q1 Earnings and Revenues Surpass Estimates

CONMED's (CNMD) first-quarter earnings reflect strong segmental performance.

PacBio's (PACB) Q1 Earnings Miss Estimates, Revenues Beat

PacBio (PACB) sees strength in Q1 segmental revenues, led by robust consumable and instrument sales.

LHC Group (LHCG) Q1 Earnings Beat Estimates, Revenues Miss

LHC Group's (LHCG) first-quarter results benefit from organic growth in both home health as well as hospice admissions.

Cardinal Health (CAH) Q3 Earnings Lag Estimates, Revenues Top

Cardinal Health's (CAH) fiscal third-quarter results benefit from a solid performance in the Pharmaceutical segment.

BD (BDX) Beats on Q2 Earnings and Revenues, Revises FY22 View

The majority of BD's (BDX) core units witness strong revenue growth in the fiscal second quarter.

Masimo's (MASI) Q1 Earnings Surpass Estimates, FY22 View Up

Masimo's (MASI) robust product shipments drive its Q1 sales.

Cerner (CERN) Q1 Earnings in Line, Revenues Lag Estimates

Cerner's (CERN) first-quarter results benefit from gains across four of its business units.

PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates

PerkinElmer's (PKI) first-quarter results benefit from a solid performance at Discover & Analytics Solutions business.

AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates

AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.

Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Decline

Robust sales performance across Omnicell's (OMCL) operating segments has contributed to the first-quarter top line.

Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?

Style Box ETF report for SLYG

Omnicell (OMCL) Q1 Earnings and Revenues Beat Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of 16.90% and 0.70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?

Style Box ETF report for SPSM

CPSI or OMCL: Which Is the Better Value Stock Right Now?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Omnicell (OMCL) Progresses With Intelligent Infrastructure Tools

Omnicell's (OMCL) IVX Station robotic compounding technology apparently supports three times the throughput speed of the current IV robotic technology.

Should SPDR S&P 600 Small Cap ETF (SLY) Be on Your Investing Radar?

Style Box ETF report for SLY

Should iShares Core S&P SmallCap ETF (IJR) Be on Your Investing Radar?

Style Box ETF report for IJR

Should Vanguard S&P SmallCap 600 ETF (VIOO) Be on Your Investing Radar?

Style Box ETF report for VIOO